Abstract
Listeria monocytogenesis an intracellular bacterium that elicits robust CD8+T-cell responses. Despite the ongoing development ofL.monocytogenes-based platforms as cancer vaccines, our understanding of howL.monocytogenesdrives robust CD8+T-cell responses remains incomplete. One overarching hypothesis is that activation of cytosolic innate pathways is critical for immunity, as strains ofL.monocytogenesthat are unable to access the cytosol fail to elicit robust CD8+T-cell responses and in fact inhibit optimal T-cell priming. Counterintuitively, however, activation of known cytosolic pathways, such as the inflammasome and type I IFN, lead to impaired immunity. Conversely, production of prostaglandin E2(PGE2) downstream of cyclooxygenase-2 (COX-2) is essential for optimalL.monocytogenesT-cell priming. Here, we demonstrate that vacuole-constrainedL.monocytogeneselicit reduced PGE2production compared to wild-type strains in macrophages and dendritic cellsex vivo.In vivo, infection with wild-typeL.monocytogenesleads to 10-fold increases in PGE2production early during infection whereas vacuole-constrained strains fail to induce PGE2over mock-immunized controls. Mice deficient in COX-2 specifically in Lyz2+or CD11c+cells produce less PGE2, suggesting these cell subsets contribute to PGE2levelsin vivo, while depletion of phagocytes with clodronate abolishes PGE2production completely. Taken together, this work demonstrates that optimal PGE2production by phagocytes depends onL.monocytogenesaccess to the cytosol, suggesting that one reason cytosolic access is required to prime CD8+T-cell responses may be to facilitate production of PGE2.
Funding Information
  • National Institutes of Health (R01CA188034)
  • National Institutes of Health (R01AI077600)
  • National Institutes of Health (T32AI55397)
  • National Science Foundation (DGE-1747503)

This publication has 77 references indexed in Scilit: